VALIDATE Annual Meeting 2021

 

Annual Meeting 2021

 

Since 2017, VALIDATE's Annual Meetings have provided members of our community with a chance to connect, network, build new collaborations and hear about some of the great research that our network has supported. Due to the COVID-19 pandemic, we were not able to meet in person so our 2021 Annual Meeting took place online, across three days: 15 September, 14 October, and 16 November 2021. We hope that by delivering an online meeting, even more members can take advantage of this opportunity to connect with fellow members and hear about the amazing work our community has undertaken over the past 4 years.

Agenda

Expand All

On 15 September 2021, over 60 VALIDATE members met on zoom to participate ifor Day One of the VALIDATE Annual Meeting 2021. The event was chaired by Prof Mitali Chatterjee and you can watch the opening session above​, which includes talks from Helen McShane, Dr Himangi Bhardawaj MBE from British High Commission in India, and an update on VALIDATE from Samantha Vermaak.

Pump Priming and Fellowship Talks - Available on the VALIDATE Hub

Day One also featured talks from three talks from recipients of our Pump Priming grants and Dr Rachel Tanner talked through her VALIDATE Fellowship Project. Some of these presentations contain unpublished data, so members need to watch them on the VALIDATE Hub.

​ 

Samantha Sampson

Day Two was chaired by VALIDATE Co Network Director Professor Sam Sampson, from Stellenbosch University, South Africa

 

You can watch the talks on the VALIDATE Hub.

 

 

 

 

 

 

 

 

 

 

 

 

   

maria adelaida gomez

Day Three was chaired by VALIDATE Network Investigator Dr Maria Adelaida Gomez, CIDEIM, Colombia

 

 

 

 

 

 

Content

US West

US East / COT

 Brazil

GMT

S.Africa

Tanzania

Iran

India

Thailand

Japan

Sydney

Welcome & Introduction

Dr Maria Adelaida Gomez & Ambassador

07:00

10:00

12:00

15:00

17:00

18:00

18:30

19:30

22:00

00:00

02:00

Talk from Ambassador

Colin Martin-Reynolds CMG, British Ambassador to Colombia

07:05

10:05

12:05

15:05

17:05

18:05

18:35

19:35

22:05

00:05

02:05

Cytomegalovirus as a risk factor for TB and leishmaniasis

Dr Lisa Stockdale, University of Oxford, UK

07:15

10:15

12:15

15:15

17:15

18:15

18:45

19:45

22:15

00:15

02:15

Elucidating the T-cell epitopes and T-cells responses of two
B.pseudomallei vaccine antigens

Dr Julen Tomás Cortázar, University College Dublin, Ireland

07:30

10:30

12:30

15:30

17:30

18:30

19:00

20:00

22:30

00:30

02:30

Investigating the BCG-induced Natural Killer (NK) cell response i
n cattle and humans

Dr Iman Satti, University of Oxford, UK

07:45

10:45

12:45

15:45

17:45

18:45

19:15

20:15

22:45

00:45

02:45

Q&A

08:00

11:00

13:00

16:00

18:00

19:00

19:30

20:30

23:00

01:00

03:00

Break

08:10

11:10

13:10

16:10

18:10

19:10

19:40

20:40

23:10

01:10

03:10

Metabolic reprogramming of skin microenvironment for improved
BCG vaccine efficacy

Titular Prof Francisco Javier Sánchez-García,
Instituto Politécnico Nacional, Mexico

08:20

11:20

13:20

16:20

18:20

19:20

19:50

20:50

23:20

01:20

03:20

Development of an RNA based vaccine Mycobacterium tuberculosis

Affiliate Prof Rhea Coler, Seattle Children's Research Institute, USA

08:35

11:35

13:35

16:35

18:35

19:35

20:05

21:05

23:35

01:35

03:35

The effect of BCG vaccination in immune responses against visceral
leishmaniasis in a natural (canine) model of infection 

Dr Isadora Lima, Oswaldo Cruz Foundation (FIOCRUZ), UK

08:50

11:50

13:50

16:50

18:50

19:50

20:20

21:20

23:50

01:50

03:50

Q&A

09:05

12:05

14:05

17:05

19:05

20:05

20:35

21:35

00:05

02:05

04:05

Break

09:15

12:15

14:15

17:15

19:15

20:15

20:45

21:45

00:15

02:15

04:15

How do functional and metabolic characteristics of trained monocytes
affect their anti-bacterial activity?

Dr Steven Smith, Brunel University, UK

09:25

12:25

14:25

17:25

19:25

20:25

20:55

21:55

00:25

02:25

04:25

Overcoming innate immune tolerance in the respiratory tract for
optimal vaccine design

Dr Rajko Reljic, SGUL, UK

09:40

12:40

14:40

17:40

19:40

20:40

21:10

22:10

00:40

02:40

04:40

Establishment of a functional assay panel to evaluate the role of
antibodies in defence against melioidosis and tuberculosis

Dr Panjaporn Chaichana, Mahidol Oxford Tropical Medicine
Research Unit (MORU), Thailand

09:55

12:55

14:55

17:55

19:55

20:55

21:25

22:25

00:55

02:55

04:55

Q&A

10:10

13:10

15:10

18:10

20:10

21:10

21:40

22:40

01:10

03:10

05:10

Break

10:20

13:20

15:20

18:20

20:20

21:20

21:50

22:50

01:20

03:20

05:20

ECR Open Forum

Mrs Samantha Vermaak, VALIDATE Network Manager

10:30

13:30

15:30

18:30

20:30

21:30

22:00

23:00

01:30

03:30

05:30